Healthcare - Biotechnology - NASDAQ - US
$ 4.33
0 %
$ 37.4 M
Market Cap
-1.01
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
24.64%
EBIT
Estimate
39.36%
Net Income
Estimate
33.81%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Lumos Pharma, Inc.
LUMO has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart LUMO
EBIT FORECAST
EBIT Forecast Chart LUMO
NET INCOME FORECAST
Net Income Chart LUMO